Karadurmus, N. Et Al. 2024. Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study. CURRENT MEDICAL RESEARCH AND OPINION .

Karadurmus, N., Kaplan, M. A., Sendur, M. A. N., ÜRÜN, Y., Demirci, U., Karaca, S. B., ... Aydin, S. G.(2024). Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study. CURRENT MEDICAL RESEARCH AND OPINION .

Karadurmus, Nuri Et Al. "Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study," CURRENT MEDICAL RESEARCH AND OPINION , 2024

Karadurmus, Nuri Et Al. "Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study." CURRENT MEDICAL RESEARCH AND OPINION , 2024

Karadurmus, N. Et Al. (2024) . "Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study." CURRENT MEDICAL RESEARCH AND OPINION .

@article{article, author={Nuri Karadurmus Et Al. }, title={Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study}, journal={CURRENT MEDICAL RESEARCH AND OPINION}, year=2024}